John Wiley & Sons Inc. (WLY)
NYSE: WLY
· Real-Time Price · USD
39.82
1.57 (4.10%)
At close: Sep 05, 2025, 3:59 PM
39.85
0.08%
After-hours: Sep 05, 2025, 06:04 PM EDT
John Wiley & Sons Revenue Breakdown
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 |
|---|---|---|---|---|---|---|---|---|
| Learning Segment Revenue | 161.86M | 137.08M | 161.51M | 124.31M | 279.46M | 146.33M | 148.94M | 515.61M |
| Learning Segment Revenue Growth | +18.07% | -15.13% | +29.92% | -55.52% | +90.98% | -1.75% | -71.11% | n/a |
| Research Segment Revenue | 280.72M | 267.54M | 261.88M | 265.31M | 13.23M | 256.2M | 257.67M | n/a |
| Research Segment Revenue Growth | +4.93% | +2.16% | -1.29% | +1905.66% | -94.84% | -0.57% | n/a | n/a |
| Held For Sale Or Sold Segment Revenue | n/a | n/a | 3.2M | 14.19M | 111.17M | 58.17M | 86.2M | n/a |
| Held For Sale Or Sold Segment Revenue Growth | n/a | n/a | -77.47% | -87.24% | +91.11% | -32.51% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Jan 31, 2019 | Oct 31, 2018 | Jul 31, 2018 | Apr 30, 2018 | Dec 6, 2017 | Oct 31, 2017 | Aug 31, 2017 | Apr 30, 2017 | Dec 9, 2016 | Oct 31, 2016 | Aug 29, 2016 | Apr 30, 2016 | Feb 29, 2016 | Dec 2, 2015 | Jul 31, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | n/a | n/a | n/a | 252.06M | 253.38M | 252.28M | 255.8M | 245.82M | 255.8M | 253.03M | 282.75M | 279.33M | 275.48M | 264.19M | 260.59M | 286.88M | 251.24M | 247.17M | 237.37M | 261.12M | 245.68M | 240.38M | 250.17M | 246.23M | 240.72M | 248.63M | 253.77M | 262.68M | 239.55M | 239.32M | 245.74M | 258.82M | 247.28M | 247.27M | 235.65M | 261.49M | 250.66M | 239.99M | 242.5M | 249.46M | 250.48M |
| Selling, General, and Administrative Revenue Growth | n/a | n/a | n/a | -100.00% | -0.52% | +0.43% | -1.38% | +4.06% | -3.90% | +1.09% | -10.51% | +1.22% | +1.40% | +4.27% | +1.38% | -9.17% | +14.19% | +1.65% | +4.13% | -9.10% | +6.28% | +2.21% | -3.91% | +1.60% | +2.29% | -3.18% | -2.03% | -3.39% | +9.66% | +0.10% | -2.61% | -5.06% | +4.67% | 0.00% | +4.93% | -9.88% | +4.32% | +4.45% | -1.04% | -2.79% | -0.41% | n/a |
| Research and Development Revenue | n/a | n/a | 4.15M | n/a | 4.94M | 4.96M | 6.25M | 6.69M | n/a | n/a | 8.16M | 8.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | -100.00% | n/a | -100.00% | -0.32% | -20.69% | -6.54% | n/a | n/a | -100.00% | -1.50% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |